Dogwood Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -83.1% | |
| – | – | – | -95.7% | +80.5% | +6.4% | -23.2% | -25.3% | |
| – | -63.6% | -407.8% | – | – | -198.5% | – | – | |
| – | – | – | -100.0% | – | -100.0% | – | -100.0% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | |
| – | – | – | – | – | – | – | -80.4% | |
| – | +106.1% | +1,307.6% | -100.3% | – | -74.2% | +1,344.5% | -56.4% | |
| – | – | +10,454.9% | -153.5% | – | – | – | -172.2% | |
| – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.